ARTHUR G JAMES CANCER HOSPITAL — History
CCN 360242 | 3-year financial timeline | COVID resilience: 60/100
🛡️ Public data only — no PHI permitted on this instance.
$1.9B
Latest Revenue (FY2022)
+6.9%
Revenue CAGR (3yr)
21.0%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $1.7B | $1.8B | $1.9B | +8.0% | +6.9% |
| Operating Expenses | $1.4B | $1.4B | $1.5B | +10.8% | +6.7% |
| Operating Margin | 20.7% | 23.0% | 21.0% | -8.7% | +0.6% |
| Net Income | $353M | $415M | $409M | -1.5% | +7.5% |
| Licensed Beds | 351 | 356 | 356 | +0.0% | +0.7% |
| Total Patient Days | 106,152 | 103,204 | 106,351 | +3.0% | +0.1% |
| Medicare Day % | 27% | 25% | 23% | -7.6% | -7.4% |
| Medicaid Day % | 4% | 5% | 5% | +5.1% | +14.2% |
COVID Impact & Recovery
Resilience Score: 60/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +14.3% ($1.7B → $1.9B)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▶ Stable
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+6.9%
This Hospital
+7.6%
State Avg
Latest Margin
21.0%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $2.1B | 21.1% |
| FY2024 (proj) | $2.2B | 21.2% |
| FY2025 (proj) | $2.3B | 21.4% |